The X-ray and fluoroscopy market — approximately $10 billion globally including interventional — is the broadest and most geographically distributed segment of the diagnostic imaging market. Digital radiography has replaced analog film across developed markets and is in rapid growth phase in emerging markets. Interventional angiography systems — used in cardiovascular, neuro, and body interventional procedures — represent the highest-value segment, with Siemens Healthineers, Philips, and GE HealthCare as the three dominant competitors in the premium interventional suite market.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• DR Market Size and Growth
• Interventional Angiography
• Mobile X-Ray
• Fluoroscopy Systems
• Emerging Market DR Expansion
• Shimadzu and Asian OEM Dynamics
• Competitive Landscape
Table of Contents
1. Executive Summary
2. Market Overview
3. DR Market Size and Growth
4. Interventional Angiography
5. Mobile X-Ray
6. Fluoroscopy Systems
7. Emerging Market DR Expansion
8. Shimadzu and Asian OEM Dynamics
9. Competitive Landscape
10. Regional Market Analysis
11. Strategic Conclusions
12. Appendix
List of Tables
Table 1. Market Size and Growth 2025
Table 2. Segment Breakdown 2025
Table 3-8. Topic-Specific Analysis Tables
Table 3. Leading Companies — Portfolio and Market Share 2025
Table 4. M&A and Innovation Activity 2023-2025
Table 5. Regional Analysis
Table 6. Key Risks and Mitigation Strategies
Companies Profiled
Canon Medical
Fujifilm
GE HealthCare
Philips
Samsung Medison
Shimadzu
Siemens Healthineers
Varex Imaging
